441![](https://www.pdfsearch.io/img/7a9cf727f3d22dea8b7940492dd50096.jpg) | Add to Reading ListSource URL: www.dornc.comLanguage: English - Date: 2014-04-16 09:01:50
|
---|
442![](https://www.pdfsearch.io/img/dcd25ed74761c1119d4417479fdccd2d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
443![](https://www.pdfsearch.io/img/4df88221f23e731c2375bb9e89fb7a01.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
444![Page 1 Transcript of FDA’s Media Briefing on Dosing Recommendations for Erythropoiesis Stimulating Agents Moderator: Kimberly Rawlings June 24, 2011 Page 1 Transcript of FDA’s Media Briefing on Dosing Recommendations for Erythropoiesis Stimulating Agents Moderator: Kimberly Rawlings June 24, 2011](https://www.pdfsearch.io/img/127cc565c2aa5872dd1e9805057e64e7.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
445![Emergence of Biosimilar Medicines The Biosimilar Company Point of View Paul Greenland, Head of Biosimilars Business Unit - EMEA Belgium Federal Parliament Emergence of Biosimilar Medicines The Biosimilar Company Point of View Paul Greenland, Head of Biosimilars Business Unit - EMEA Belgium Federal Parliament](https://www.pdfsearch.io/img/6460994a0704a8da07bed4987255f142.jpg) | Add to Reading ListSource URL: www.egagenerics.comLanguage: English |
---|
446![Microsoft PowerPoint - NYMFSQL MFData[removed]S Myer.ppt Microsoft PowerPoint - NYMFSQL MFData[removed]S Myer.ppt](https://www.pdfsearch.io/img/3c6af02db51f9952998b8c0d9b4c2c31.jpg) | Add to Reading ListSource URL: www.ipd.gov.hkLanguage: English - Date: 2013-01-07 02:40:51
|
---|
447![5 Mittwoch, 26. Juni 2013 · Nr. 49 8 Amgen meistert Patentklippe 5 Mittwoch, 26. Juni 2013 · Nr. 49 8 Amgen meistert Patentklippe](https://www.pdfsearch.io/img/2f7507cbd55b976ae668c2e4c6069403.jpg) | Add to Reading ListSource URL: www.kn-portal.comLanguage: German - Date: 2013-07-10 07:01:14
|
---|
448![Pediatric Ethics Subcommittee of the Pediatric Advisory Committee Pediatric Ethics Subcommittee of the Pediatric Advisory Committee](https://www.pdfsearch.io/img/312b9f22db41ad9b9873695a2b0678c3.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2008-12-08 09:50:55
|
---|
449![Pediatric Ethics Subcommittee of the Pediatric Advisory Committee Pediatric Ethics Subcommittee of the Pediatric Advisory Committee](https://www.pdfsearch.io/img/c7d75da987a265e84c2bc9c42c28fde6.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2008-12-03 13:16:49
|
---|
450![INTERIM DOCUMENT Facts About Neupogen® When a person has received a very high dose of radiation, destruction of the bone marrow, potentially resulting in uncontrolled bleeding and infection, is a major concern. To help INTERIM DOCUMENT Facts About Neupogen® When a person has received a very high dose of radiation, destruction of the bone marrow, potentially resulting in uncontrolled bleeding and infection, is a major concern. To help](https://www.pdfsearch.io/img/44c7cbcc86b3989f8fd41553d3a1da66.jpg) | Add to Reading ListSource URL: www.bt.cdc.govLanguage: English - Date: 2006-10-26 16:22:37
|
---|